Article
T cell receptor repertoire in cell-free DNA as a proxy for tumor infiltrates in patients treated with pembrolizumab
27 Aug 2025
Abstract excerpt
Profiling tumor and systemic T cell receptor (TCR) repertoires can identify features associated with the clinical benefit of patients with cancer on immune checkpoint blockade therapy. This study reports on the diversity and specificity analysis of TCR sequences from 58 tumor, 306 peripheral blood mononuclear cell (PBMC), and 73 cell-free DNA (cfDNA) samples from 81 patients with solid tumors treated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
